292 related articles for article (PubMed ID: 19450182)
1. Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation.
Jones CV; Copelan EA
Future Oncol; 2009 May; 5(4):559-68. PubMed ID: 19450182
[TBL] [Abstract][Full Text] [Related]
2. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
Valcárcel D; Martino R
Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
[TBL] [Abstract][Full Text] [Related]
3. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
Craddock CF
Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
[TBL] [Abstract][Full Text] [Related]
4. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.
Sengsayadeth S; Savani BN; Blaise D; Malard F; Nagler A; Mohty M
Haematologica; 2015 Jul; 100(7):859-69. PubMed ID: 26130513
[TBL] [Abstract][Full Text] [Related]
5. Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.
Chemnitz JM; von Lilienfeld-Toal M; Holtick U; Theurich S; Shimabukuro-Vornhagen A; Krause A; Brossart P; Hallek M; Scheid C
Ann Hematol; 2012 Jan; 91(1):47-55. PubMed ID: 21584670
[TBL] [Abstract][Full Text] [Related]
6. [Current indications of allogeneic stem cell transplant in adults with acute myeloid leukemia].
Thomas X
Bull Cancer; 2014 Sep; 101(9):856-65. PubMed ID: 25296413
[TBL] [Abstract][Full Text] [Related]
7. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
Lekakis L; de Lima M
Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission: have the indications changed?
Paun O; Lazarus HM
Curr Opin Hematol; 2012 Mar; 19(2):95-101. PubMed ID: 22227526
[TBL] [Abstract][Full Text] [Related]
9. Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison.
Mohty M; de Lavallade H; El-Cheikh J; Ladaique P; Faucher C; Fürst S; Vey N; Coso D; Stoppa AM; Gastaut JA; Chabannon C; Blaise D
Leukemia; 2009 Jan; 23(1):194-6. PubMed ID: 18580956
[No Abstract] [Full Text] [Related]
10. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
de Lima M; Giralt S
Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need.
Shimoni A; Nagler A
Best Pract Res Clin Haematol; 2011 Sep; 24(3):369-79. PubMed ID: 21925090
[TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'.
Kassim AA; Chinratanalab W; Ferrara JL; Mineishi S
Bone Marrow Transplant; 2005 Oct; 36(7):565-74. PubMed ID: 15995714
[TBL] [Abstract][Full Text] [Related]
13. Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia.
Hamilton BK; Copelan EA
Stem Cells; 2012 Aug; 30(8):1581-6. PubMed ID: 22653712
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
Niederwieser D; Gentilini C; Hegenbart U; Lange T; Becker C; Wang SY; Bartsch K; Pönisch W; Raida M; Al-Ali H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):275-81. PubMed ID: 16213741
[TBL] [Abstract][Full Text] [Related]
15. Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?
Ustun C; DeFor TE; Rashidi A; Devine S; Miller J; Weisdorf D
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1804-1808. PubMed ID: 28688918
[No Abstract] [Full Text] [Related]
16. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?
Song KW; Lipton J
Bone Marrow Transplant; 2005 Aug; 36(3):183-91. PubMed ID: 15937497
[TBL] [Abstract][Full Text] [Related]
17. High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
Schmid C; Schleuning M; Hentrich M; Markl GE; Gerbitz A; Tischer J; Ledderose G; Oruzio D; Hiddemann W; Kolb HJ
Bone Marrow Transplant; 2008 Apr; 41(8):721-7. PubMed ID: 18176613
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality.
Meijer E; Cornelissen JJ
Semin Oncol; 2008 Aug; 35(4):449-57. PubMed ID: 18692695
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective.
Yanada M
Int J Hematol; 2015 Mar; 101(3):243-54. PubMed ID: 25212675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
